BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 25952334)

  • 1. Iron accumulation in the basal ganglia in Huntington's disease: cross-sectional data from the IMAGE-HD study.
    Domínguez JF; Ng AC; Poudel G; Stout JC; Churchyard A; Chua P; Egan GF; Georgiou-Karistianis N
    J Neurol Neurosurg Psychiatry; 2016 May; 87(5):545-9. PubMed ID: 25952334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated brain iron is independent from atrophy in Huntington's Disease.
    Dumas EM; Versluis MJ; van den Bogaard SJ; van Osch MJ; Hart EP; van Roon-Mom WM; van Buchem MA; Webb AG; van der Grond J; Roos RA;
    Neuroimage; 2012 Jul; 61(3):558-64. PubMed ID: 22480728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered brain iron content and deposition rate in Huntington's disease as indicated by quantitative susceptibility MRI.
    Chen L; Hua J; Ross CA; Cai S; van Zijl PCM; Li X
    J Neurosci Res; 2019 Apr; 97(4):467-479. PubMed ID: 30489648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRI evaluation of basal ganglia ferritin iron and neurotoxicity in Alzheimer's and Huntingon's disease.
    Bartzokis G; Tishler TA
    Cell Mol Biol (Noisy-le-grand); 2000 Jun; 46(4):821-33. PubMed ID: 10875443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered iron and myelin in premanifest Huntington's Disease more than 20 years before clinical onset: Evidence from the cross-sectional HD Young Adult Study.
    Johnson EB; Parker CS; Scahill RI; Gregory S; Papoutsi M; Zeun P; Osborne-Crowley K; Lowe J; Nair A; Estevez-Fraga C; Fayer K; Rees G; Zhang H; Tabrizi SJ;
    EBioMedicine; 2021 Mar; 65():103266. PubMed ID: 33706250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of quantitative susceptibility mapping methods for iron-sensitive susceptibility imaging at 7T: An evaluation in healthy subjects and patients with Huntington's disease.
    Yao J; Morrison MA; Jakary A; Avadiappan S; Chen Y; Luitjens J; Glueck J; Driscoll T; Geschwind MD; Nelson AB; Villanueva-Meyer JE; Hess CP; Lupo JM
    Neuroimage; 2023 Jan; 265():119788. PubMed ID: 36476567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shape analysis of subcortical nuclei in Huntington's disease, global versus local atrophy--results from the TRACK-HD study.
    van den Bogaard SJ; Dumas EM; Ferrarini L; Milles J; van Buchem MA; van der Grond J; Roos RA
    J Neurol Sci; 2011 Aug; 307(1-2):60-8. PubMed ID: 21624624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Automated differentiation of pre-diagnosis Huntington's disease from healthy control individuals based on quadratic discriminant analysis of the basal ganglia: the IMAGE-HD study.
    Georgiou-Karistianis N; Gray MA; Domínguez D JF; Dymowski AR; Bohanna I; Johnston LA; Churchyard A; Chua P; Stout JC; Egan GF
    Neurobiol Dis; 2013 Mar; 51():82-92. PubMed ID: 23069680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multimodal imaging biomarkers in premanifest and early Huntington's disease: 30-month IMAGE-HD data.
    D JF; Stout JC; Poudel G; Churchyard A; Chua P; Egan GF; Georgiou-Karistianis N
    Br J Psychiatry; 2016 Jun; 208(6):571-8. PubMed ID: 26678864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study protocol of IMAGINE-HD: Imaging iron accumulation and neuroinflammation with 7T-MRI + CSF in Huntington's disease.
    van de Zande NA; Bulk M; Najac C; van der Weerd L; de Bresser J; Lewerenz J; Ronen I; de Bot ST
    Neuroimage Clin; 2023; 39():103450. PubMed ID: 37327706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seeking Huntington disease biomarkers by multimodal, cross-sectional basal ganglia imaging.
    Sánchez-Castañeda C; Cherubini A; Elifani F; Péran P; Orobello S; Capelli G; Sabatini U; Squitieri F
    Hum Brain Mapp; 2013 Jul; 34(7):1625-35. PubMed ID: 22359398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reproducibility of R
    Santin MD; Didier M; Valabrègue R; Yahia Cherif L; García-Lorenzo D; Loureiro de Sousa P; Bardinet E; Lehéricy S
    NMR Biomed; 2017 Apr; 30(4):. PubMed ID: 26913373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered ventral striatal activation during reward and punishment processing in premanifest Huntington's disease: a functional magnetic resonance study.
    Enzi B; Edel MA; Lissek S; Peters S; Hoffmann R; Nicolas V; Tegenthoff M; Juckel G; Saft C
    Exp Neurol; 2012 May; 235(1):256-64. PubMed ID: 22366326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basal ganglia-cortical structural connectivity in Huntington's disease.
    Novak MJ; Seunarine KK; Gibbard CR; McColgan P; Draganski B; Friston K; Clark CA; Tabrizi SJ
    Hum Brain Mapp; 2015 May; 36(5):1728-40. PubMed ID: 25640796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal metabolite changes in Huntington's disease during disease onset.
    van den Bogaard SJ; Dumas EM; Teeuwisse WM; Kan HE; Webb A; van Buchem MA; Roos RA; van der Grond J
    J Huntingtons Dis; 2014; 3(4):377-86. PubMed ID: 25575959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MR relaxometry in Huntington's disease: correlation between imaging, genetic and clinical parameters.
    Vymazal J; Klempír J; Jech R; Zidovská J; Syka M; Růzicka E; Roth J
    J Neurol Sci; 2007 Dec; 263(1-2):20-5. PubMed ID: 17585943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data.
    Tabrizi SJ; Reilmann R; Roos RA; Durr A; Leavitt B; Owen G; Jones R; Johnson H; Craufurd D; Hicks SL; Kennard C; Landwehrmeyer B; Stout JC; Borowsky B; Scahill RI; Frost C; Langbehn DR;
    Lancet Neurol; 2012 Jan; 11(1):42-53. PubMed ID: 22137354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MRI measures of corpus callosum iron and myelin in early Huntington's disease.
    Di Paola M; Phillips OR; Sanchez-Castaneda C; Di Pardo A; Maglione V; Caltagirone C; Sabatini U; Squitieri F
    Hum Brain Mapp; 2014 Jul; 35(7):3143-51. PubMed ID: 24895252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-modal neuroimaging in premanifest and early Huntington's disease: 18 month longitudinal data from the IMAGE-HD study.
    Domínguez D JF; Egan GF; Gray MA; Poudel GR; Churchyard A; Chua P; Stout JC; Georgiou-Karistianis N
    PLoS One; 2013; 8(9):e74131. PubMed ID: 24066104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI T2 Hypointensities in basal ganglia of premanifest Huntington's disease.
    Jurgens CK; Jasinschi R; Ekin A; Witjes-Ané MN; Middelkoop H; van der Grond J; Roos RA
    PLoS Curr; 2010 Sep; 2():. PubMed ID: 20877453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.